Ophthalmology Update - Cleveland Clinic

More documents

Recommendations

Info

i n n O v a t i O n Innovation We push the boundaries at every step of the way, refusing to be saddled by conventional thinking or limitations. // O p h t h a l m O l O g y U p d a t e s p e c i a l e d i t i O n 2 0 0 6
Who We Are at the cole eye institute, the lines between research and patient care blur. the belief that the two are interdependent and synergistic is the foundation for everything we do. We believe that this approach enhances diagnosis and advances treatment, to the benefit of our patients today and tomorrow. Our program ranks high in the U.S.News & World Report annual survey, and is consistently the highest rated in Ohio. We have some of the highest patient volumes in the United states, handling more than 150,000 patient visits and more than 5,000 surgeries per year. We offer treatment of the full range of vision disorders and conditions, as well as offering routine eye care for all ages. Our internationally recognized staff of 26 ophthalmologists is composed almost entirely of subspecialists, and eight optometrists round out our comprehensive services. Our state-of-the-art building demonstrates our dedication to patients and to the tradition established by the founders of cleveland clinic – a commitment to world-class care that always puts the patient first as well as providing further education for those who serve. Our facilities are designed for maximum patient comfort, service and quality. We offer one-stop eye care, with our diagnostic services suite located just a quick elevator ride away from the clinical suites, and our state-of-the-art operating rooms also are on premises. all windows in the patient areas feature special light filters to minimize the discomfort of patients whose eyes are dilated or newly treated. Our waiting rooms are designed to be comfortable and include a special area for children to play while they wait. We also have a pearle vision on site and offer such amenities as valet parking and an easy drive-up area for pick-up of postoperative patients. Our regional eye care program provides services in five suburban locations throughout the greater cleveland area, including one ambulatory surgery center. i n n O v a t i O n <strong>Cleveland</strong> <strong>Clinic</strong> Cole Eye Institute is one of the few dedicated, comprehensive state-of-the-art eye institutes in the world. We are here to serve the needs of patients and referring physicians by providing early, accurate diagnosis and excellent, effective patient care. We strive daily to make this commitment to innovation a reality. We are pioneering treatment protocols for complex vision-threatening disorders, including age-related macular degeneration and glaucoma, through our clinical trials program. Our aggressive research program bridges the gap between laboratory and patient care, and our team of dedicated researchers works in some of the most well-equipped labs anywhere. Other unique programs housed at Cole Eye Institute: The Center for Genetic Eye Diseases: the center for genetic eye diseases provides clinical diagnostic and therapeutic services for patients with inherited eye conditions such as corneal and retinal dystrophies and microphthalmia. patients with inherited disorders that involve the eye, such as neurofibromatosis, albinism, neurodegenerative disorders and marfan syndrome, are referred to the center by physicians from around the country. a monthly specialty clinic is dedicated to patients with retinal dystrophies and their families. A National Eye Donor Program: cole eye institute houses the Foundation Fighting Blindness’ center for eyes donated by individuals across the United states for blindness research. the center shares tissue samples with researchers worldwide. Formally known as the retinal degeneration pathophysiology Facility, the collection center accepts eye donations after death from any person of any age who has normal vision or any degree of vision loss resulting from a retinal-degenerative disease. cole eye institute staff prepares a detailed medical report about each donated eye to help researchers track the effects of eye disease in different types of people and environments. prior to moving to cleveland clinic, the center was located in philadelphia. For more information about our services or to refer a patient, please call 216.444.2020 or 800.223.2273 ext 42020 or visit clevelandclinic.org/eye. c O l e e y e i n s t i t U t e c l e v e l a n d c l i n i c . O r g / e y e //
Page 1 and 2: Cleveland Clinic Cole Eye Institute
Page 3 and 4: i n v e s t i g a t i O n s Dear Co
Page 5 and 6: Cole Eye Researchers Aiming to Eluc
Page 7 and 8: useful prognostic tools and (2) the
Page 9 and 10: Studies on Redox-Sensitive Retinal
Page 11 and 12: Diverse Spectrum of New and Investi
Page 13 and 14: CSNB Mouse Models Provide Valuable
Page 15 and 16: Study Conclusively Links Haze After
Page 17 and 18: Corneal Biomechanical Clues Studied
Page 19 and 20: Autologous Serum Eyedrops May Offer
Page 21 and 22: Switching from ECCE to Phacoemulsif
Page 23 and 24: lens. that technique has also been
Page 25 and 26: NEI-Sponsored Study Evaluating Role
Page 27 and 28: Case Study: Five-Month-Old Boy Pres
Page 29 and 30: Study Investigates Risk Factors for
Page 31 and 32: however, a few months later she ret
Page 33 and 34: each trial will enroll 189 adult pa
Page 35: Briefly, after everting the eyelid,
Page 39 and 40: Refractive Surgery FREEInG pATIEnTs
Page 41 and 42: Cole Eye Institute Staff Hilel Lewi
Page 43 and 44: Allen S. Roth, M.D. Comprehensive O
Page 45 and 46: International Ophthalmology Reviewe
Page 47 and 48: Heed Ophthalmic Foundation Executiv
Page 49 and 50: Training the Leaders of Tomorrow e
Page 51 and 52: Continuing Medical Education e d U
Page 53 and 54: Innovations in Ophthalmology los Ca
Page 55 and 56: description/Objectives: This course
Page 57 and 58: e d U c a t i O n a n d t r a i n i
Page 59 and 60: Distinguished Lecture Series e d U
Page 61 and 62: Research We will never stop pursuin
Page 63 and 64: AMD Initiative for Prevention and C
Page 65 and 66: A 3-Year, phase 3, multicenter, mas
Page 67 and 68: Traboulsi EI. The challenges and su
Page 69 and 70: Nakata K, Crabb JW, Hollyfield JG.
Page 71 and 72: Journal of neuroscience Bjartmar L,
Page 73 and 74: Singh AD. Ophthalmic oncology - pre
Page 75: Netto MV, Ambrosio R, Jr., Wilson S
Page 78: MKT 05-EYE-036

Ophthalmology Update - Cleveland Clinic

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?